Quantitative Characterization of α-Synuclein Aggregation in Living Cells through Automated Microfluidics Feedback...

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Alpha-synuclein (α-synuclein) aggregation and inclusion formation are key pathological features of Parkinson's disease (PD).
• Previous studies on α-synuclein aggregation have been limited by cell-free systems, neglecting the influence of the cellular environment.
• Understanding dynamic protein regulation within cells is crucial for elucidating PD pathogenesis.

Purpose of the Study:

• To quantitatively analyze α-synuclein inclusion formation and clearance in a dynamic cellular environment.
• To investigate the concentration-dependent aggregation of wild-type (WT) and A53T mutant α-synuclein.
• To determine the role of proteasomal and autophagic pathways in the clearance of α-synuclein inclusions.

Main Methods:

• Utilized a yeast cell model expressing WT or A53T mutant α-synuclein under a galactose-inducible promoter.
• Employed a computer-controlled microfluidics device for precise, closed-loop regulation of α-synuclein expression levels.
• Chemically modulated proteasomal and autophagic pathways to assess their impact on inclusion clearance.

Main Results:

• Demonstrated that α-synuclein inclusion formation is strictly concentration-dependent.
• Established that the A53T mutant α-synuclein has a lower aggregation threshold (56%) compared to WT α-synuclein.
• Confirmed that autophagy is the primary pathway responsible for the clearance of A53T α-synuclein inclusions.

Conclusions:

• Developed a novel technological approach for dynamic protein expression regulation in cellular studies.
• Provided quantitative insights into the concentration-dependent nature of α-synuclein aggregation in a cellular context.
• Highlighted the critical role of autophagy in clearing toxic α-synuclein aggregates, offering potential therapeutic targets for Parkinson's disease.